Abstract
For the treatment of different leukemia different chemotherapies are available. However the success rate of any particular drug scheduling may vary with leukemic condition. In general, low dose of chemotherapy is suggested for chronic leukemia, whereas application of high dose (myeloablative) chemotherapy is applied for acute and vigorous type of leukemia. In present work we have shown that chronic type of leukemia is controlled; however, for controlling vigorously growing leukemia is a challenge due to chemotherapeutic toxicity to the normal cells of the hematopoietic system. Hence for its management, we developed a control analysis model. This model may help to design an optimal chemotherapeutic schedule so that the controlling of the vigorously growing leukemic growth can be possible in one hand with the sustenance of the normal non-leukemic cell population on the other hand. This work shows that for long-term chemotherapeutic success in individual leukemic patients demands a judicious choice of drug dosing strategy that may determine the trade-off between leukemic growth and restoration time of normal cell population of the hematopoietic system.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ogawa, M.: Differentiation and proliferation of hematopoietic stem cells. Blood 81, 2844–2853 (1993)
Orkin, S.H.: Hematopoiesis: how does it happen? Curr. Opin. Cell Biol. 7, 870–877 (1995)
Peschle, C., Botta, R., Muller, R., Valtieri, M., Ziegler, B.: Purification and functional assay of pluripotent haematopoietic stem cells. Rev. Clin. Exp. Hematol. 5, 3–14 (2001). https://doi.org/10.1046/j.1468-0734.2001.00029.x
Rubinow, S.I., Lebowitz, J.L.: A mathematical model of the acute myeloblastic leukemic state in man. Biophys. J. 16, 897–910 (1976). https://doi.org/10.1016/S0006-3495(76)85740-2
Rubinow, S.I., Lebowitz, J.L.: A mathematical model of the chemotherapeutic treatment of acute myeloblastic leukemia. Biophys. J. 16, 1257–1271 (1976). https://doi.org/10.1016/S0006-3495(76)85772-4
Djulbegovic, B., Svetina, S.: Mathematical model of acute myeloblastic leukaemia: an investigation of the relevant kinetic parameters. Cell Prolif. 18, 307–319 (1985)
Colijn, C., Mackey, M.C.: A mathematical model of hematopoiesis—I. Periodic chronic myelogenous leukemia. J. Theoret. Biol. 237, 117–132 (2005)
Colijn, C., Mackey, M.C.: A mathematical model of hematopoiesis: II. Cyclical neutropenia. J. Theoret. Biol. 237, 133–146 (2005)
Colijn, C., Fowler, A.C., Mackey, M.C.: High frequency spikes in long period blood cell oscillations. J. Math. Biol. 53, 499–519 (2006). https://doi.org/10.1007/s00285-006-0027-9
Haurie, C., Dale, D.C., Rudnicki, R., Mackey, M.C.: Modeling complex neutrophil dynamics in the grey collie. J. Theoret. Biol. 204, 505–519 (2000)
Michor, F., Hughes, T.P., Iwasa, Y., Branford, S., Shah, N.P., et al.: Dynamics of chronic myeloid leukemia. Nature 435, 1267–1270 (2005). https://doi.org/10.1038/nature03669
ten Cate, B., de Bruyn, M., Wei, Y., Bremer, E., Helfrich, W.: Targeted elimination of leukemia stem cells: a new therapeutic approach in hemato-oncology. Curr. Drug Targets 11, 95–110 (2010). https://doi.org/10.2174/138945010790031063
Kim, P.S., Lee, P.P., Levy, D.: Dynamics and potential impact to chronic myelogenous leukemia. PLoS Comput. Biol. 4, e1000095 (2008). https://doi.org/10.1371/journal.pcbi.1000095
Peet, M.M., Kim, P.S., Niculescu, S.I., Levy, D.: New computational tools for modeling chronic myelogenous leukemia. Math. Model. Nat. Phenom. 4, 48–68 (2009). https://doi.org/10.1051/mmnp/20094203
Pefani, E., Panoskaltsis, N., Mantalaris, A., Georgiadis, M.C., Pistikopoulos, E.N.: Design of optimal patient-specific chemotherapy protocols for the treatment of acute myeloid leukemia. Comput. Chem. Eng. 57, 187–195 (2013)
Pefani, E., Panoskaltsis, N., Mantalaris, A., Georgiadis, M.C., Pistikopoulos, E.N.: Chemotherapy drug scheduling for the induction treatment of patients with acute myeloid leukemia. IEEE Trans. Biomed. Eng. 61, 2049–2056 (2014). https://doi.org/10.1109/TBME.2014.2313226
Savvopoulos, S., Misener, R., Panoskaltsis, N., Pistikopoulos, E.N., Mantalaris, A.: A personalized framework for dynamic modeling of disease trajectories in chronic lymphocytic leukemia. IEEE Trans. Biomed. Eng. 63, 2396–2404 (2016). https://doi.org/10.1109/TBME.2016.2533658
Dhar, P.K., Mukherjee, A., Majumder, D.: Difference delay equation based analytical model of hematopoiesis. Autom. Control Physiol. State Funct. 1, 1–11 (2012). https://doi.org/10.4303/acpsf/235488
Dhar, P.K., Majumder, D.: Development of the analytical model for the assessment of the efficiencies of different therapeutic modalities in leukaemia. J. Comput. Syst. Biol. 1, 1–45 (2015). https://doi.org/10.15744/2455-7625.1.104
Dhar, P.K., Naskar, T.K., Majumder, D.: Analytical model for the assessment of efficiency of stem cell transplantation with suicidal gene construct for the treatment of leukemia. J. Oncol. Trans. Res. 1, 1–5 (2015). https://doi.org/10.4172/jotr.1000103
Yi, S., Nelson, P.W., Ulsoy, A.G.: Analysis and control of time delayed systems via the Lambert W funtion. In: Proceedings of 17th World Congress, The International Federation of Automatic Control, Seoul, Korea, pp. 13414–13419 (2008)
Kitano, H.: Violations of robustness trade-offs. Mol. Syst. Biol. 6, 1–8 (2010). https://doi.org/10.1038/msb.2010.40
Gatenby, R.A.: A change of strategy in the war on cancer. Nature 459, 508–509 (2009)
Mukherjee, A., Majumder, D.: Dynamical model for the assessment of anti-angiogenic therapy of cancer. Mol. BioSyst. 6, 1047–1055 (2010)
Majumder, D., Mukherjee, A.: A passage through systems biology to systems medicine: adoption of middle-out rational approaches towards the understanding of clinical outcome in cancer therapy. Analyst 136, 663–678 (2011). https://doi.org/10.1039/c0an00746c
Majumder, D., Mukherjee, A.: Multi-scale modeling approaches in systems biology towards the assessment of cancer treatment dynamics: adoption of middle-out rationalist approach. Adv. Cancer Res. Treat. 2013, Article ID 587889 (2013). https://doi.org/10.5171/2013/587889
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Dhar, P.K., Naskar, T.K., Majumder, D. (2018). An Analytical Approach for the Determination of Chemotherapeutic Drug Application Trade-Offs in Leukemia. In: Bhattacharyya, P., Sastry, H., Marriboyina, V., Sharma, R. (eds) Smart and Innovative Trends in Next Generation Computing Technologies. NGCT 2017. Communications in Computer and Information Science, vol 827. Springer, Singapore. https://doi.org/10.1007/978-981-10-8657-1_30
Download citation
DOI: https://doi.org/10.1007/978-981-10-8657-1_30
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-8656-4
Online ISBN: 978-981-10-8657-1
eBook Packages: Computer ScienceComputer Science (R0)